Suzhou Ribo Life Science Co. Ltd.

7 clinical trials · Sponsor

Record	Firm	Date
Single Ascending Doses Phase I Study to Evaluate the Safety and Pharmacokinetics of RBD1119 in Healthy Participants (NCT07042594)	Suzhou Ribo Life Science Co. Ltd.	2025-08-26
A Study of RBD1016 in CHB Participants (NCT05961098)	Suzhou Ribo Life Science Co. Ltd.	2023-10-11
A Single and Multiple Ascending Doses Study to Evaluate the Safety, Tolerability and Pharmacokinetics of RBD7022 (NCT05912296)	Suzhou Ribo Life Science Co. Ltd.	2023-05-30
A Single Ascending Doses Phase I Study to Evaluate the Safety and Pharmacokinetics of RBD4059 in Healthy Subjects (NCT05653037)	Suzhou Ribo Life Science Co. Ltd.	2023-03-21
A Single and Multiple Ascending Doses Study to Evaluate the Safety and Pharmacokinetics of RBD5044 (NCT05539651)	Suzhou Ribo Life Science Co. Ltd.	2022-11-10
A Single and Repeated Dose Escalation of RBD1016 in Subjects with Chronic Hepatitis B Virus (HBV) Infection (NCT05017116)	Suzhou Ribo Life Science Co. Ltd.	2021-08-09
A Single Dose-escalation Study to Evaluate the Safety and Pharmacokinetics of RBD1016 (NCT04685564)	Suzhou Ribo Life Science Co. Ltd.	2021-02-05

Every clearance here is in the API, with alerts when new ones post.